Ullas Batra, Co-Director, Dept of Medical Oncology and Chief of Thoracic Medical Oncology at Rajiv Gandhi Cancer Institute and Research Centre, shared a post on LinkedIn:
“Presenting our latest publication where ten years of treating ALK-positive lung cancer is distilled into one study. We are celebrating a decade of teamwork, research and advances in precision oncology that continue to shape the future of lung cancer treatment.”
Title: A Decade of Treating ALK‑Rearranged Non‑Small Cell Lung Cancer in a Lower Middle‑Income Country: Changing Patterns and Improving Survival
Authors: Ullas Batra, Mansi Sharma, Irfan Ahmad, Senthil Rajappa, Shrinidhi Nathany, Luca Cantini, Rashi Sachdeva, Vanshika Batra, Ritwika Choudhury, Bhumi Agarwal, Abhinav Dewan, Sabeena Choudhary, B. P. Amrith, L. M. Darlong, Kundan Singh Chufal, Preetha Umesh, Kratika Bhatia, Paulo Nunes Filho, Kamal S. Saini, Anurag Mehta
You Can Also Read:
